RxDoctor Payments Data

Dominic Cefali, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Newburgh, INNPI 1588638639

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,912 of the $4,642 with a category attached, or 84.3%. 18 manufacturers reported payments, led by Edwards Lifesciences at 46.4% of the total. Reporting peaked in 2022 at $924 and has fallen 61.9% since, to $352 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in IN, where the typical reported total is $4,642.

$4,642in general payments, 2019–2025

Across 132 payments — averaging $35.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2K
  • Atricure, Inc.$1K
  • Johnson & Johnson$216
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$188
  • Medtronic$171
  • Abbott$156
  • plus $411 from 12 others
$20,479in research payments, 2019–2025

Across 7 payments — averaging $2925.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$20K

What the payments were for

  • Travel & lodging$73016%
  • Food & beverage$3,91284%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,642 in reported general payments places this provider in the 50th percentile of 127 thoracic surgery (cardiothoracic vascular surgery) providers in Indiana.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Indiana

Medicare billing

Part B allowed, 2024
$221,837
Medicare patients
282
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic11$920
Losartan Potassium43$439
Metoprolol Tartrate54$262
ClopidogrelClopidogrel Bisulfate41$250
Metoprolol Succinate28$244
Atorvastatin Calcium33$223
Lisinopril19$137
Pantoprazole Sodium11$42

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →